NewsBenzingaMilestone Pharmaceuticals annuncia misure di efficienza dei costi per ridurre le proprie spese operative di circa il 30%, completate entro il primo trimestre del 2027; prevede di sostenere oneri una tantum di circa 2 milioni di dollari. Milestone Pharmaceuticals annuncia misure di efficienza dei costi per ridurre le proprie spese operative di circa il 30%, completate entro il primo trimestre del 2027; prevede di sostenere oneri una tantum di circa 2 milioni di dollari. Benzinga 2026.11.13 12:13 (GMT+0) Open on Benzinga Other news Jensen Huang Faces Subpoena Threat As 3 Republican-Led House Committees Demand Closed-Door Testimony Over Nvidia’s China Ties Sigma Lithium Q3 EPS $(0.23), Sales $13.522M Columbia Banking System Board Raises Quarterly Cash Dividend From $0.37 To $0.38 Per Share Piper Sandler Upgrades Americold Realty Trust to Overweight, Raises Price Target to $19 Piper Sandler Downgrades Hancock Whitney to Neutral, Lowers Price Target to $71.5 Rosenblatt Maintains Buy on Cisco Systems, Lowers Price Target to $140
Jensen Huang Faces Subpoena Threat As 3 Republican-Led House Committees Demand Closed-Door Testimony Over Nvidia’s China Ties
